Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.

Seongjae KimJung Min ParkSoeun ParkEunsun JungDongmi KoMinsu ParkJuyeon SeoKee Dal NamYong Koo KangKyoungmin LeeLee FarrandYoon-Jae KimJi Young KimJae Hong Seo

Published in: Journal of experimental & clinical cancer research : CR (2023)

Our findings highlight the potential of DOXA as a therapeutic option for metastatic TNBC, warranting further investigation.

Keyphrases

small cell lung cancer
tyrosine kinase
epidermal growth factor receptor
squamous cell carcinoma
human health